Minneapolis – April 9, 2026
CLEVELAND & DALLAS–(BUSINESS WIRE)–Align Capital Partners’ (“ACP”) drug and alcohol testing solutions provider Premier Biotech (“Premier” or the “Company”) has acquired GH Solutions (“GH”), a distributor of point-of-care diagnostic testing products. GH Solutions serves customers across the United States, primarily in the government and workplace end markets.
Minneapolis – December 3, 2025
MINNEAPOLIS–(BUSINESS WIRE)–Premier Biotech (“Premier” or the “Company”), a fully integrated provider of drug and alcohol solutions, announced today that Rod Weis has joined the Company as its new Chief Revenue Officer (CRO). This strategic hire reinforces Premier’s commitment to innovation and growth in the drug and alcohol testing industry.
Minneapolis – November 5, 2025
CLEVELAND & DALLAS–(BUSINESS WIRE)–Align Capital Partners’ (“ACP”) drug and alcohol testing solutions provider Premier Biotech (“Premier” or the “Company”) has acquired National Test Systems (“NTS”), a leading provider of rapid point-of-care diagnostic drug screening supplies and services throughout the United States.
Minneapolis – April 10, 2025
CLEVELAND & DALLAS–(BUSINESS WIRE)–Align Capital Partners’ (“ACP”) toxicology testing solutions provider Premier Biotech (“Premier” or the “Company”) completed two successive acquisitions including OraSure Technologies, Inc.’s (“OTI”) substance abuse testing business line (the “OraSure Toxicology Line”), and separately, the Mexican subsidiary of Green Earth Biomedical LLC (“GEM”), an international provider of drug testing solutions.
Minneapolis – June 6, 2024
MINNEAPOLIS, MN and SCOTTSDALE, AZ June 6, 2024 /PRNewswire/ — Premier Biotech, LLC (“Premier”), one of the nation’s leading toxicology solutions providers, today announced that it has completed the acquisition of Desert Tox LLC, a laboratory testing provider certified by the Substance Abuse and Mental Health Services Administration (“SAMHSA”).
Minneapolis – June 9, 2020
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to the COVID-19 IgG and IgM rapid test manufactured by Hangzhou Biotest Biotech, Co., Ltd. (“Biotest”) and distributed by Premier Biotech, used for the qualitative detection and differentiation of IgM and IgG antibodies against SARS-CoV-2 in whole blood, serum, or plasma.
Minneapolis (Star Tribune) – June 14, 2020
The Food and Drug Administration granted an emergency-use authorization (EUA) for the test on June 4, and posted the results of an independent performance assessment by the National Cancer Institute…
Minneapolis (WCCO) – April 16, 2020
A Minnesota company is involved in a first of its kind antibody test study that’s going to Major League Baseball teams all over the country…
Minneapolis (CNBC) – April 20, 2020
According to new research from the University of Southern California and the LA Department of Public Health…
Dr. Lisa Larkin on CNN with Anderson Cooper – April 16, 2020
Dr. Lisa Larkin (Lisa Larkin, MD, and Associates) discusses COVID-19 antibody testing with Anderson Cooper…
WZZM 13 – April 16, 2020
Dr. Laurie Birkholz is one of the first doctors in West Michigan to offer COVID-19 antibody testing. The blood tests show if a body has produced antibodies…
LMT Online – April 16, 2020
An urgent care clinic with two locations in Houston’s suburbs is one of the few local facilities offering a unique test that identifies patients with COVID-19 antibodies…
The Stanford Daily – April 4, 2020
COVID-19 antibody tests differ from nasal swab tests currently employed by healthcare providers both in method and results…
Business Wire – September 25, 2018
This clearance represents another landmark achievement that demonstrates the ongoing commitment of the company to invest in the design, development and commercialization of near-donor solutions for the toxicology market….
COVID-19 (Coronavirus) Rapid Test
The COVID-19 IgG and IgM rapid test manufactured by Hangzhou Biotest Biotech, Co., Ltd. and distributed by Premier Biotech is used for the qualitative detection of SARS-CoV-2 antibodies in whole blood, serum, or plasma.
Action News Jax – May 17, 2018
Minneapolis Lab Uncovers Deadly Opioid Mixes In Jacksonville Patients
All the urine samples from Project Save Lives participants are analyzed by Minneapolis-based Premier Biotech…
Press and Media Inquiries
Are you a media professional interested in speaking with us? Please reach out to marketing@premierbiotech.com.
For sales inquiries, please reach out here.
Current customers with questions should contact support@premierbiotech.com.